30 Days of MD: Marie De Graaf 30 Days of MD: Marie De Graaf by Kevin Schaefer | September 11, 2020 View this post on Instagram Day 11 of 30 Days of MD Topic: Accepting Life with Charcot-Marie-Tooth This is@marie_charcotmarietooth ’s story: Shame. As a child I was ashamed of my thin calves and ankles. Why were mine so thin? In my teens I found out during gym class that it was very difficult for me to walk on my toes and heels. Running was also very difficult for me. I have very long legs, I have an athletic build, so why was I running so weird and slow and was I often tired? I was diagnosed with CMT type 2 (charcot-marie-tooth disease) around the age of fourteen. I was very ashamed of something that I couldn’t control. I always wore long pants, hiding my legs and feet. I was always very aware of the environment (if I go this way no one sees me walking), when people asked why I walked like that, I made up excuses. Years passed, I was offered aids such as insoles for your shoes to make walking easier. I was a little less ashamed of what I had, I told some friends about it, because my feet had grown crooked, they could hurt a lot while walking. Friends had to know that I was suffering from CMT, because you can’t hide pain. When I was 27 years old I looked at the possibilities for people with CMT and then I decided to have an operation, they tightened my ankles (triple arthrodesis) and straightened my toes. I was offered leg braces and since then I have been practically painless through life and walking has become so much easier. Since I passed the age of 30 the shame has been much less, I wear skirts with pride and people can see my braces and therefore my condition. I hope when I turn 40 that the shame is completely gone and that I finally fully embrace my condition. Time will tell. #MDAwarenessMonth #MDAwareness #30daysofmd A post shared by MDNewsToday (@mdnewstoday) on Sep 11, 2020 at 7:11am PDT Print This Page Tags 30 days of MD, Marie De Graaf, MD awareness month
November 14, 2024 News by Marisa Wexler, MS FDA OKs trial to test gene therapy candidate in LGMD children